Anxiety is one of the most pervasive, undiscussed emotions in our society. Many of us feel it—a subtle nervousness or stress that we can’t quite understand and that serves as a sort of filter through which we experience the world. There’s many different types of anxiety, too, from the anxiety associated with terminal diagnosis to social anxiety. In this 75-minute webinar, Dr. Charles Grob discusses the promise of psychedelics to heal anxiety. We also cover his career-long inquiry into the promise and limitations of psychedelic science—why are psychedelic clinical trials important for the movement? And also, what might be lost or even unstudiable about these sacred compounds?
*The proceeds from our events go towards paying our guests and funding our free journalism to destigmatize psychedelics. If you cannot afford the sliding scale, email hello@doubleblindmag.com to be registered
About Dr. Charles Grob
Dr. Charles Grob’s clinical interests include mood and anxiety disorders, as well as substance use. His research has included the first FDA approved Phase 1 study of the physiological and psychological effects of MDMA (3,4-
